Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Supreme Court Remands Fosamax Lawsuits Over Atypical Fracture Warnings May 21, 2019 Austin Kirk Add Your Comments The U.S. Supreme Court has issued a new opinion which clarifies the standard drug makers must meet to establish a federal “pre-emption” defense, which is often used by pharmaceutical companies to try to escape liability for failing to warn about known risks associated with medications they sell, arguing that the FDA would not have permitted a label update. All nine justices joined or concurred in the decision, which found that a judge, not a jury, must determine that there is “clear evidence” the drug maker fully informed the FDA about the justifications for adding such a warning, and that the FDA, in turn, informed the drug maker that the agency would not approve a change to include that warning. As a result of the ruling, the nation’s highest court remanded hundreds of Fosamax lawsuits over failure to warn about the risk of atypical bone fractures. The cases will be sent back to a lower appeals court to determine whether Merck can establish the pre-emption defense under the newly articulated standards. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Each of the claims involve allegations that side effects of Fosamax caused users to suffer a sudden femur fracture, which typically occur with little or no trauma. Plaintiffs claim that the drug maker knew about the bone fracture risk for years after Fosamax was introduced, but withheld information from consumers and the medical community until the FDA required a label update in 2010. Merck has attempted to defend the case by arguing that the FDA would not have allowed a warning update before 2010, since the agency previously rejected a proposed label update about the risk of “stress fractures”. However, it will be a judicial question to determine whether that prior action would pre-empt claims for failure to warn about the more serious atypical femur fractures at issue in the case. In the majority opinion, Justice Stephen Breyer pointed out that Merck once again proposed a “stress fracture” warning in 2010, which the FDA rejected again when it required the stronger warning about atypical fractures. “Merck was initially resistant to the [2010 FDA label] change, proposing revised language that, once again, referred to the risk of ‘stress fractures’,” Justice Breyer wrote. “But the FDA, once again, rejected that language. And this time, the FDA explained that ‘the term ‘stress fracture’ was considered and was not accepted’ because, ‘for most practitioners, the term ‘stress fracture’ represents a minor fracture and this would contradict the seriousness of the atypical femoral fractures associated with bisphosphonate use.” While the justices remanded the case to the Court of Appeals for further proceedings consistent with the opinion, Justice Clarence Thomas suggested in a concurring opinion that the Court should have rejected Merck’s pre-emption defense as a matter of law, indicating that Merck has been unable to point to any statute, regulation or other agency action that provides the force of federal law necessary to prohibit the drug maker from adding warning. The Fosamax lawsuits will now be remanded back to the U.S. Court of Appeals for the Third Circuit for further proceedings. Tags: Drug Side Effects, Femur Fracture, Fosamax, Merck, Supreme Court More Lawsuit Stories More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies April 17, 2025 AngioDynamics SmartPort Infection Resulted in Removal of Failed Port Catheter: Lawsuit April 17, 2025 Allstate Driving Data Collection Lawsuits Consolidated in Northern District of Illinois April 17, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (Posted: yesterday) Nearly a dozen different cosmetics companies face more than 12,000 hair relaxer lawsuits, involving claims that chemical straighteners caused women to develop uterine cancer, endometrial cancer, ovarian cancer and other injuries. MORE ABOUT: HAIR RELAXER LAWSUITUterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025) Paraquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (Posted: 2 days ago) Lawyers involved in Paraquat Parkinson’s disease lawsuits pending in the federal court system indicate that they have reached an agreement to settle many of the claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSAppeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)Farmers Exposed to Certain Pesticides Face an Increased Risk of Rheumatoid Arthritis (12/11/2024) Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (Posted: 2 days ago) A federal judge will meet with lawyers involved with Suboxone tooth loss lawsuits tomorrow, to review the status of pretrial proceedings in claims brought by individuals throughout the U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITPrenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)Suboxone Lawsuit Filing Deadline Nears for Many Tooth Decay Claims in 3-Year SOL States (04/07/2025)Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (03/17/2025)
More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies April 17, 2025
AngioDynamics SmartPort Infection Resulted in Removal of Failed Port Catheter: Lawsuit April 17, 2025
Allstate Driving Data Collection Lawsuits Consolidated in Northern District of Illinois April 17, 2025
More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (Posted: yesterday) Nearly a dozen different cosmetics companies face more than 12,000 hair relaxer lawsuits, involving claims that chemical straighteners caused women to develop uterine cancer, endometrial cancer, ovarian cancer and other injuries. MORE ABOUT: HAIR RELAXER LAWSUITUterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)
Paraquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (Posted: 2 days ago) Lawyers involved in Paraquat Parkinson’s disease lawsuits pending in the federal court system indicate that they have reached an agreement to settle many of the claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSAppeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)Farmers Exposed to Certain Pesticides Face an Increased Risk of Rheumatoid Arthritis (12/11/2024)
Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (Posted: 2 days ago) A federal judge will meet with lawyers involved with Suboxone tooth loss lawsuits tomorrow, to review the status of pretrial proceedings in claims brought by individuals throughout the U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITPrenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)Suboxone Lawsuit Filing Deadline Nears for Many Tooth Decay Claims in 3-Year SOL States (04/07/2025)Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (03/17/2025)